Skip to content

A Study on the Therapeutic Effects of Xifeng Hua Tan Tongluo Decoction (with Addition and Subtraction) Combined with Behavioral Therapy for Children with Liver Hyperactivity and Wind Movement Type Tic Disorders

A Study on the Therapeutic Effects of Xifeng Hua Tan Tongluo Decoction (with Addition and Subtraction) Combined with Behavioral Therapy for Children with Liver Hyperactivity and Wind Movement Type Tic Disorders

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000191
Enrollment
Unknown
Registered
2026-01-28
Start date
2025-06-10
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tourette syndrome

Interventions

Control Group:Western medicine
Traditional Chinese Medicine Group:Traditional Chinese Medicine (TCM)
Comprehensive Group:Traditional Chinese Medicine and Behavioral Therapy

Sponsors

Hebei Provincial Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria of Western medicine and Traditional Chinese Medicine (TCM). 2. Aged between 3 and 14 years (inclusive of 3 and 14 years old). 3. Score on the Yale Global Tic Severity Scale (YGTSS) ranges from 20 to 50 points. 4. The child and their legal guardian fully understand the purpose, methods, potential risks, and benefits of this study and voluntarily sign the informed consent form, committing to adhering to the study protocol, including taking medication, attending behavioral therapy sessions, and regular follow-ups.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with other types of tic-related disorders. 2. History of allergy to the traditional Chinese medicine or conventional Western medicine used in this study. 3. Received other treatments targeting tic disorders within the past month. 4. Accompanied by severe psychological issues, such as major depression or anxiety disorders. 5. Presence of intellectual disabilities, language disorders, or other conditions that prevent cooperation in scale assessments and treatments. 6. Suffering from genetic metabolic diseases, such as phenylketonuria or hepatolenticular degeneration. 7. Currently participating in other drug clinical trials or interventional studies.

Design outcomes

Primary

MeasureTime frame
The Yale Global Tic Severity Scale (YGTSS) was used to assess the recovery of symptoms;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Score;The quality of life scale was used to evaluate the improvement of quality of life;Incidence of Adverse Reactions;

Countries

China

Contacts

Public ContactYinguilei

Hebei Provincial Traditional Chinese Medicine Hospital

ygl9827@163.com17302200610

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026